Viewing Study NCT05861895


Ignite Creation Date: 2025-12-24 @ 2:19 PM
Ignite Modification Date: 2026-01-02 @ 12:59 AM
Study NCT ID: NCT05861895
Status: RECRUITING
Last Update Posted: 2024-08-01
First Post: 2023-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors
Sponsor: HighField Biopharmaceuticals Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module